suvorexant
Merck releases insomnia drug in US
February 4, 2015Sales and Marketing FDA, Merck, belsomra, insomnia, orexin, suvorexant
Merck’s insomnia drug Belsomra is now available in the US to treat patients who have difficulty falling asleep or staying …
FDA experts recommend Merck sleep pill
May 24, 2013Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant
Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …
Merck releases new Phase III insomnia data
September 11, 2012Research and Development, Sales and Marketing Merck, insomnia, suvorexant
Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …
Merck’s sleep aid drug meets goals
June 15, 2012Research and Development, Sales and Marketing FDA, Merck, insomnia, sleep disorder, suvorexant
Merck’s novel insomnia drug suvorexant has improved patients’ ability to fall asleep, according to new data from two Phase III …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026
Tridem begins phase Ib trial of Parkinson’s disease vaccine
October 13, 2026
